CYTOAURORA BIOTECHNOLOGIES, INC.
Update：2026/11/10
Industries
Main Industry
Biotechnology
Main Product/Service
The blood detection chip developed by CytoAurora is based on Taiwan's semiconductor technology, combined with self-developed artificial intelligence software, and integrated molecular pathology technology to develop a world-leading cancer detection equipm
The content above was translated by Ai
Founded Year
2015
Unified Business No.
42579799
Status
Active
Number of Employees
0
Total Paid-in
Capital
88,018,000 (NT$)
Location of Company
Taiwan
, Hsinchu County
Overseas Development
France、Japan、Thailand
Company names, registration status, legal representatives, founding years, paid-in capital, registered addresses, and other details are sourced from business registration records maintained by Taiwan’s Administration of Commerce, Ministry of Economic Affairs. Exit status includes Emerging Stock Board listings, M&A, and IPOs. Information on overseas expansion is self-reported by startups.
Note 1: FINDIT compiles company information from public and other sources for reference and does not serve as a point of contact for the companies listed.
Note 2: Some company profiles and product/service descriptions are translated using AI and provided for reference only. In case of discrepancies or ambiguity, the original text prevails.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Established in 2015, CytoAurora Biotechnology actively promotes cross-field integration, hoping to introduce the biotechnology and medical industry with the advantages of Taiwan's semiconductor and electronics industries, and is committed to the research and development of innovative cell biotechnology and equipment, which can be applied to gene and protein research. Aim at the research and development in the field of precision medicine, provide more accurate medical services, and give back to the society.
The content above was translated by Ai
